Definitive Contract HHSD200201795855C
Award Date
9/1/17
Potential Completion Date
12/1/19
Potential Value
$1M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $120,229,963 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Georgia Research Foundation, Inc. (UGA Research Foundation) to design and evaluate innovative influenza vaccine approaches based on principles of influenza immunity that achieve durable, robust, and broadly protective immunity. The contract is part of the Collaborative Influenza Vaccine Innovation Centers (CIVICS) program and does not utilize a set-aside...
This federal contract award is for the development of an adjuvant for a thermostable respiratory influenza vaccine. The contract, valued at $599,749.00, was awarded to Universal Stabilization Technologies, Inc. by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases under the Small Business Innovation Research (SBIR) Program Phase I. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and the...
This is a definitive contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to the University of Georgia Research Foundation, Inc. (UGA Research Foundation), a non-profit organization, in the amount of $659,708. The contract, which has a firm fixed price, is for research and services related to avian influenza. The contract does not have a set-aside designation and was awarded on September 30, 2019, with a completion date of...
This is a Definitive Contract awarded by the Centers for Disease Control and Prevention (CDC) to Universal Stabilization Technologies, Inc., a for-profit organization, for the PPLB SABIN IPV STABILIZATION PROJECT FOR OTHER FUNCTIONS. The contract is a Firm Fixed Price contract with a ceiling value of $199,953.72 and an ultimate completion date of April 23, 2016. The contract was awarded on August 24, 2015 and was not set aside for any specific business type. The place of performance is San...
This is a $93,053,895 definitive federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Georgia Research Foundation, Inc. (UGA Research Foundation) to support the NIAID Centers of Excellence for Influenza Research and Response. The contract has a period of performance from April 1, 2021 to September 14, 2027 and is not set aside for any specific business category. The contract supports an integrated research network focused on influenza...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $249,996.00 firm fixed-price purchase order to the University of Georgia Research Foundation, Inc. (UGA Research Foundation) for the production of polyclonal ferret antisera to influenza virus. UGA Research Foundation is a non-profit organization that manages sponsored programs and federal contracts for the University of Georgia. This contract is not associated with a larger acquisition vehicle and...
This federal contract award, valued at $16,731,358.00, was made by the National Institute of Allergy and Infectious Diseases (NIAID) to the Access To Advanced Health Institute (AAHI), a non-profit biotech research institute. The contract is for the continued development of vaccine candidates for biodefense, antimicrobial resistance, emerging infectious diseases, and respiratory pathogens. No set-aside designation was used. AAHI has subcontracted with several institutions, including Emory...
This is a $748,885 firm-fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute based in Seattle, Washington. The contract is for research and development of intranasal administration of RNA vaccines against respiratory pathogens. The contract was awarded under an Ease Broad Agency Announcement (EZ-BAA) issued by the Division of Research, Innovation, and...
This federal contract award, valued at $7,521,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Protein Sciences Corp, a for-profit manufacturer, to conduct research, development, manufacturing, and testing of vaccine candidates, antigens, proteins, seed lots, and assays to support medical countermeasure preparedness against influenza strains and COVID-19. The award is part of the Department of Health and Human Services' (HHS) Office of the Assistant Secretary for...
This $642,000.00 firm-fixed-price delivery order was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Seqirus USA Inc. through its Seqirus Usa, Inc. division. The order was placed under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract, a multi-year vehicle managed by ASPR. The contract supports the delivery of influenza vaccines, which Seqirus specializes in manufacturing and supplying to various...